"Corporate Value and Return Enhancement" Action Plan 2026
Filed with SSE · · 4 pages · Chinese
Earlier from Guobang Pharma
- Announcement on Investment in a New Project by the Company’s Wholly-owned Subsidiary
- Announcement on Progress and Implementation Result of Shares Repurchase and Share Changes
- Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
- Announcement on the Completion of Non-Trading Transfer and Purchase under the Phase II Employee Stock Ownership Plan
- Announcement on Progress in Implementing Phase II Employee Stock Ownership Plans
Later from Guobang Pharma
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on the Acquisition of Approval Documents for Veterinary Drug Product Approval Number by the Wholly-owned Subsidiary
- Announcement on Progress in Wholly-owned Subsidiary Participating in the Establishment of Equity Investment Fund
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Plan for Repurchasing Shares through Call Auction and Repurchase Report
Follow Guobang Pharma into a list and get an email when it puts out news.
Follow Guobang Pharma